Ind-Swift Laboratories schedules 31st AGM for September 30, 2026
- Ind-Swift Laboratories holds 31st AGM on September 30, 2026 via VC/OAVM
- Annual report for FY26 submitted to BSE and NSE on September 5, 2026
- Share transfer books closed from September 24 to September 30, 2026
- Voting cut-off date fixed at September 23, 2026 per Companies Act rules

*this image is generated using AI for illustrative purposes only.
Ind-Swift Laboratories Limited will hold its 31st Annual General Meeting (AGM) on September 30, 2026. The event will be conducted via Video Conferencing/Other Audio Visual Means (VC/OAVM) starting at 3:00 pm.
The company submitted its annual report for the financial year 2025-26 (FY26) to the stock exchanges. The filing was made in compliance with Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Dates and Procedures
The cut-off date for determining voting entitlement is September 23, 2026. This aligns with Section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014.
Share transfer books will remain closed from September 24, 2026, to September 30, 2026. This closure facilitates the AGM process as mandated by regulatory guidelines.
| Event | Date | Details |
|---|---|---|
| Cut-off date | September 23, 2026 | Voting entitlement determination |
| Book closure start | September 24, 2026 | Share transfer books closed |
| AGM date | September 30, 2026 | VC/OAVM mode at 3:00 pm |
| Book closure end | September 30, 2026 | Share transfer books reopen |
Pardeep Verma, VP-Corporate Affairs & Company Secretary, signed the submission letter dated September 5, 2026. The notice includes procedures for remote e-voting before and during the meeting.
Historical Stock Returns for Ind Swift Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.49% | -0.58% | +55.69% | +159.38% | +247.03% | +405.61% |
What specific financial performance metrics or strategic initiatives are expected to be highlighted in the FY26 annual report?
How might the proposed dividend policy or capital allocation plans discussed at the AGM impact shareholder returns in the near term?
Are there any significant changes to the board of directors or executive management team anticipated during the September 30 meeting?


































